Developmental aspects of selected antiviral chemotherapeutic agents.
D000547:Amantadine / Q000627:therapeutic use; D000998:Antiviral Agents / Q000627:therapeutic use*; D001087:Arabinonucleosides / Q000627:therapeutic use; D004279:DNA, Viral / Q000096:biosynthesis; D004341:Drug Evaluation; D006566:Herpesviridae Infections / Q000188:drug therapy; D006801:Humans; D007065:Idoxuridine / Q000627:therapeutic use; D007251:Influenza, Human / Q000188:drug therapy; D008720:Methisazone / Q000627:therapeutic use; D012899:Smallpox / Q000517:prevention & control; D014764:Viral Proteins / Q000096:biosynthesis; D014777:Virus Diseases / Q000188:drug therapy*; D014780:Viruses / Q000254:growth & development
D000998:Antiviral Agents; D001087:Arabinonucleosides; D004279:DNA, Viral; D014764:Viral Proteins; D000547:Amantadine; D008720:Methisazone; D007065:Idoxuridine